Skip to main content

Table 1 Age and body mass indices (BMI) of men in each caffeine treatment group (means ± SEM)

From: Caffeine administration does not alter salivary α-amylase activity in young male daily caffeine consumers

 

Caffeine treatment Ggroups

 

Placebo (N = 15)

200 mg (N = 15)

400 mg (N = 15)

Age (years)

22.00 ± 0.60

20.67 ± 0.58

21.07 ± 0.80

Body mass index (kg/m2)

23.43 ± 0.70

23.64 ± 0.80

23.11 ± 0.57

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us